Colgate-Palmolive Company $CL Shares Sold by Generali Investments Management Co LLC

Generali Investments Management Co LLC cut its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 79.3% in the third quarter, Holdings Channel.com reports. The fund owned 2,967 shares of the company’s stock after selling 11,394 shares during the period. Generali Investments Management Co LLC’s holdings in Colgate-Palmolive were worth $237,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Brighton Jones LLC grew its stake in shares of Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after buying an additional 450 shares in the last quarter. Woodline Partners LP boosted its holdings in Colgate-Palmolive by 76.3% during the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock valued at $4,344,000 after acquiring an additional 20,062 shares during the period. Schnieders Capital Management LLC. grew its position in Colgate-Palmolive by 2.0% in the 2nd quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock valued at $1,136,000 after acquiring an additional 245 shares in the last quarter. Envestnet Asset Management Inc. increased its stake in Colgate-Palmolive by 0.4% during the second quarter. Envestnet Asset Management Inc. now owns 678,352 shares of the company’s stock worth $61,662,000 after purchasing an additional 2,768 shares during the period. Finally, Bessemer Group Inc. lifted its position in shares of Colgate-Palmolive by 16.0% during the second quarter. Bessemer Group Inc. now owns 19,264 shares of the company’s stock worth $1,751,000 after purchasing an additional 2,650 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on CL shares. Morgan Stanley lifted their price objective on shares of Colgate-Palmolive from $87.00 to $100.00 and gave the company an “overweight” rating in a report on Monday, February 2nd. Citigroup boosted their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Monday, February 2nd. Rothschild & Co Redburn set a $93.00 price objective on Colgate-Palmolive in a research report on Friday, February 13th. Argus reiterated a “hold” rating on shares of Colgate-Palmolive in a report on Thursday, December 11th. Finally, Wells Fargo & Company boosted their target price on Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a research note on Sunday, February 1st. Eleven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $94.75.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, COO Panagiotis Tsourapas sold 15,000 shares of the company’s stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $97.81, for a total value of $1,467,150.00. Following the completion of the transaction, the chief operating officer owned 10,415 shares in the company, valued at $1,018,691.15. This represents a 59.02% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider John Hazlin sold 20,989 shares of the firm’s stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total value of $1,978,213.25. Following the transaction, the insider directly owned 17,645 shares in the company, valued at approximately $1,663,041.25. The trade was a 54.33% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 184,683 shares of company stock worth $17,486,693 in the last ninety days. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $99.01 on Friday. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $100.18. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.27. The firm has a market capitalization of $79.81 billion, a PE ratio of 37.79, a price-to-earnings-growth ratio of 4.40 and a beta of 0.29. The business’s fifty day moving average price is $87.49 and its 200 day moving average price is $82.73.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The business had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. During the same period in the prior year, the firm posted $0.91 EPS. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. On average, sell-side analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st were paid a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.1%. The ex-dividend date was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 79.39%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.